Results 221 to 230 of about 52,178 (281)

Structure-guided design of antibody CDRs to reduce their reactivity to treatment-emergent anti-drug antibodies. [PDF]

open access: yesMAbs
Johansson MU   +13 more
europepmc   +1 more source

Engineered extracellular vesicles-mediated curcumin delivery in brain microenvironment modulating lysosomes, mitochondria, and microglia reprogram for parkinson's disease therapy. [PDF]

open access: yesJ Nanobiotechnology
Shie MY   +13 more
europepmc   +1 more source

Deciphering Protein Corona by scFv-Based Affinity Chromatography

open access: yesNano Letters, 2021
It remains challenging to precisely decipher the structural and functional characteristics of protein coronas. To overcome the drawbacks frequently occurring in the traditional separation methods, an anti-PEG single-chain variable fragment (PEG-scFv ...
Cheng Li, Xiaoli Wei, Tianlei Ying
exaly   +5 more sources
Some of the next articles are maybe not open access.

Related searches:

ScFv Improvement Approaches.

Protein & Peptide Letters, 2018
The most common recombinant antibody format is the single chain fragment variable (scFv) which it contains the complete antigen-binding domains of an intact antibody. ScFv fragments have found vast medical and non-medical applications. Several approaches have been employed to increase the affinity, avidity and structural stability related to these ...
Peyman Bemani   +2 more
semanticscholar   +3 more sources

Rapid, Point-of-Care scFv-SERS Assay for Femtogram Level Detection of SARS-CoV-2

open access: yesACS Sensors, 2022
Rapid, sensitive, on-site identification of SARS-CoV-2 infections is an important tool in the control and management of COVID-19. We have developed a surface-enhanced Raman scattering (SERS) immunoassay for highly sensitive detection of SARS-CoV-2 ...
Patrick Alfred Johnson, J Gerard Wall
exaly   +2 more sources

Tuning the ignition of CAR: optimizing the affinity of scFv to improve CAR-T therapy

open access: yesCellular and Molecular Life Sciences, 2021
Chan Liao, Yong-Min Tang, Chun Zhou
exaly   +2 more sources

Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo

open access: yesNature Biotechnology, 2018
The efficacy of chimeric antigen receptor (CAR) T cell therapy against poorly responding tumors can be enhanced by administering the cells in combination with immune checkpoint blockade inhibitors.
Sarwish Rafiq   +2 more
exaly   +2 more sources

Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodies

open access: yesScience Translational Medicine, 2020
T cell–bispecific antibody antitumor function is maximized through optimal interdomain spacing and dual cis-configurations. The specifics of bispecifics T cell–bispecific antibodies, which are designed to bring T cells together with tumor cells and ...
Brian H Santich   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy